BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Apoptosis, Pseudomonas infection, Endothelial cell, Biofuel, Bleomycin, rs6983267)
Bookmark Forward

QuickView for FcRn (gene)


Body Atlas

Most Correlated Tissues

  1. Fetal lung
  2. Whole blood
  3. Liver
  4. Microglial cell
  5. Neutrophil of bone marrow
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Disease due to Orthopoxvirus
  2. 11p partial monosomy syndrome
  3. Placental insufficiency
  4. Microbial culture finding
  5. Drug resistance
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. P79 protein, human
  2. TV 5010
  3. enterotoxin F, Staphylococcal
  4. fluvastatin
  5. gelsemine
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. MIR150
  2. ARX
  3. FEZF1-AS1
  4. AXIN1
  5. NKX2-3
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Differential effects of FcRn antagonists on the subcellular trafficking of FcRn and albumin.
  2. Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic co…
  3. Efgartigimod as a novel FcRn inhibitor for autoimmune disease.
  4. Neonatal Fc receptor (FcRn)-A Novel Therapeutic Approach for Autoimmune Disease].
  5. The neonatal Fc receptor (FcRn) is a pan-arterivirus receptor.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Role of the Neonatal Fc Receptor for IgG in the Pathophysiology of Lupus
  2. Study of Neonatal IgG Fc Receptor Expression in Natural Killer T Cells Expressing an Invariant T Rec…
  3. A Study of the Safety and Effectiveness of Efgartigimod in Patients With Primary Sjögren's Syndrome …
  4. A Phase I Study Evaluating the Safety, Tolerability, PK and PD in Healthy Chinese Volunteers
  5. Treatment of Pregnancy RA
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.